💥 I am adding a #BSKY account! I am @Bernardafox.bsky.social / Expect posts from #immunotherapy & #melanoma #Bridge2024 meetings in #Napoli #Italy in 10d. @sitcancer @ASCO @AACR @ImmunologyAAI @iuis_online @ChilesResearch @carlobifulco @PAscierto @parkerici @Chrystal_Paulos

Appreciate @oncodaily⁩ publishing LinkedIn post highlighting world’s 1st cancer’s #DarkMatter #immunotherapy! This strategy has tripled response rates! ⁦@UbiVac⁩ looking to move this off-the-shelf drug to other #cancers ⁦@ChilesResearch⁩

ITS A WRAP! For me, #JPM2025 was all #cancer ‘s #DarkMatter. What it is? What TCRs see & do they explain tripling of response rate in pts receiving combo IO with @UbiVac ‘s DPV-001 @Regeneron @incyte @agenus @novartis @parkerici @PAscierto #FinishCancer @OregonBizAssoc @Asthika

Here is preprint! Bird Flu is adapting to more easily spread to other animals & potentially humans. US Gov awarded $306M for monitoring & preparedness/Experimental #vaccines in development/ #CDC @US_FDA @#NIAID #NIH #H5N1 #BirdFlu #vaccinesWork

On Day 1 of 2025 want to thank @oncodaily for shout out & share their post. While early, this is promising news for patients with head & neck #cancer #HNSCC lots of people responsible @romleidner @rbryanbell @WalterUrba @carlobifulco @WWredmond4 @Shawn_M_Jensen @ChilesResearch

RT @business: Elon Musk was first to shoot down Congress’s plans to avert a US government shutdown, a demonstration of his influence at the…

💥 Work in #Tumor #Immunology #cancer #immunotherapy #Tcell #Bcell ? THINKING OF JOINING #Bluesky ??? I think you should consider it @sitcancer @ImmunologyAAI @AACR @ASCO @myESMO Communities of scientists are emerging on Bluesky @bernardafox.bsky.com

💥READ THIS! Wonderful Insight into Americans’ Anger, Anxiety, & Concern with #Health Care & #Insurance Companies. ER Doc @helenouyang.bsky.social wrote opinion piece in today’s @nytimes #RonWyden #UHC #Elevence #Centene #Kaiser #Humana #Aetna #HCSC

#Bridge2024 coming to a close! Saturday, 7DEC2024 2PM & entering last session/will cover 1st line #immunotherapy, salvage, igniting change in #cancer #vaccine development, combo IO, #PD1 refractory & more @Merck #BIOTECH @bmsnews @Replimune @UbiVac @BioNTech_Group @moderna_tx

RT @BcellBruno: This is amazing!!! You don’t have to convince me! @aruthak @JoeYeong @poholeklab @tonyrcillo @jishnu1729 @PancPathologist

RT @JoeYeong: Working on(rather than toward) the future, we are. :) Cant wait to share with all our recently published Nature paper (in pr…

RT @JimMansfieldYWG: Wow! What a big day for #multipleximaging and #spatialbio! I am proud to have played a role in the genesis of this fie…

Prof. @BcellBruno @UPMC gives great talk.. to see what she said .. join BSKY Prof @JennGuerriero joined!! So did @RobertFerrisMD See @bernardafox.bsky.social for posts from #Bridge2024 #vivenko @sitcancer @PAscierto @sitcancer @JoeYeong @carlobifulco @DrBetofMDPhD

Prof Oliver Michelin #spatiomics expert @ Univ de #Geneve & talks graph based methods to assess cell infiltrates. Most data “DO NOT POST” #JEDIcouncil #Bridge2024 #multiomics #USCAP #AI #DigitalPathology #FinishCancer MORE ON BSKY @aruthak @JoeYeong @carlobifulco

Another GREAT DEBATE! Prof. @Chrystal_Paulos @EmoryUniversity debates with Prof @DrBetofMDPhD @StanfordCancer at start majority thinks it will be better to engineer TIL/ WHO WON? See video/ #Bridge2024 @sitcancer #adoptive #immunotherapy MORE ON BSKY @BernardAFox.bsky.social

Prof Iman Osman #melanoma #immunotherapy expert @NYUTischSchool #LangoneCancerCenter attacks unanswered question. What to do with #NF1 mutant melanoma? Great-DO NOT POST DATA #EGFR #BRAF / #BRIDGE2024 #Vivenko #FinishCancer MORE ON BSKY at @BernardAFox.bsky.social @PAscierto

Prof Mitch Levesque #omics expert @ #Uni #Zurich / Amazing #melanoma resources available to investigators/#TMA, cell lines, & more / sc mel phenotypes/ talking fast/ #FinishCancer @PAscierto LOTS MORE DATA ON BSKY @BernardAFox.bsky.social @Melanoma_doctor

MORE DETAILS ON BSKY See @BernardAFox.bsky.social Prof. Christian Blank #melanoma #immunotherapy Guru @NKI_nl talks on #LRG1 a molecule that appears to ID patients that need additional therapy. Anti-#LRG1 may also be a therapeutic #Bridge2024 @Melanomaonmymin @CureMelanoma

#Melanoma #Bridge2024 Program / more posts on BSKY - see @BernardAFox.bsky.social I am leaving #Twitter @sitcancer @sitcancerECS

WORK HARD, PLAY HARD! #Immunotherapy #Bridge2024 is over & the 15th #Melanoma Bridge. Great being in Napoli with so many friends.@PAscierto @DrChoueiri @OmidHamidMD @HTawbi_MD @DrBetofMDPhD @BcellBruno @SamirNKhleif @sitcancer @GalonJerome @IAmDrDex @JennGuerriero #Napoli